10-Q/A XBRL

FORM 10-Q/A

Company: AEON Biopharma, Inc.
Filed: June 11, 2025
Period of Report: March 31, 2025
Accession Number: 0001104659-25-058535

View Document ↗ View on SEC.gov ↗